Platform Genomics: How Aurora Therapeutics Plans to Unclog the CRISPR Pipeline by Redefining Regulatory Approval.
The revolutionary promise of CRISPR-Cas9, once hailed as the biotechnology breakthrough of the century, has entered a phase of sobering commercial reality. Since its emergence from academic labs around 2013,…
